» Articles » PMID: 24358406

Prevention of Early-onset Neonatal Group B Streptococcal Disease

Overview
Date 2013 Dec 21
PMID 24358406
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Streptococcus agalactiae, also known as Group B Streptococcus (GBS), is an opportunistic pathogen that colonizes the gastrointestinal and genitourinary tracts of up to 50% of healthy adults and newborns; it is responsible for significant morbidity and mortality. Early detection can be used to establish the use of antibiotic prophylaxis to significantly reduce neonatal sepsis. This article reviews methods of detection and prevention of GBS infection in the neonate.

Citing Articles

Updates on Group B Infection in the Field of Obstetrics and Gynecology.

Choi Y, Han H, Chong G, Le T, Nguyen H, Lee O Microorganisms. 2022; 10(12).

PMID: 36557651 PMC: 9780959. DOI: 10.3390/microorganisms10122398.


Prevention of young infant infections using oral azithromycin in labour in Fiji (Bulabula MaPei): study protocol of a randomised control trial.

Hume-Nixon M, Ratu T, Clark S, Nguyen C, Neal E, Pell C BMJ Open. 2022; 12(12):e061157.

PMID: 36456016 PMC: 9716885. DOI: 10.1136/bmjopen-2022-061157.


Clinical features and antimicrobial susceptibility profiles of culture-proven neonatal sepsis in a tertiary children's hospital, 2013 to 2017.

Li X, Ding X, Shi P, Zhu Y, Huang Y, Li Q Medicine (Baltimore). 2019; 98(12):e14686.

PMID: 30896617 PMC: 6709008. DOI: 10.1097/MD.0000000000014686.


Isolation and molecular characterization of group B from laboratory Long-Evans rats () with and without invasive group B streptococcal disease.

Winn C, Bakthavatchalu V, Esmail M, Feng Y, Dzink-Fox J, Richey L J Med Microbiol. 2017; 67(1):97-109.

PMID: 29160197 PMC: 5884963. DOI: 10.1099/jmm.0.000627.


Evidence of accessibility and utility of point-of-care diagnostics as an integral part of prevention of mother-to-child transmission services: systematic scoping review protocol.

Katoba J, Hangulu L, Mashamba-Thompson T BMJ Open. 2017; 7(11):e017884.

PMID: 29102993 PMC: 5695340. DOI: 10.1136/bmjopen-2017-017884.


References
1.
Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A . Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC. MMWR Recomm Rep. 2002; 51(RR-11):1-22. View

2.
Huber C, McOdimba F, Pflueger V, Daubenberger C, Revathi G . Characterization of invasive and colonizing isolates of Streptococcus agalactiae in East African adults. J Clin Microbiol. 2011; 49(10):3652-5. PMC: 3187314. DOI: 10.1128/JCM.01288-11. View

3.
Heath P, Balfour G, Weisner A, Efstratiou A, Lamagni T, Tighe H . Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet. 2004; 363(9405):292-4. DOI: 10.1016/S0140-6736(03)15389-5. View

4.
Brimil N, Barthell E, Heindrichs U, Kuhn M, Lutticken R, Spellerberg B . Epidemiology of Streptococcus agalactiae colonization in Germany. Int J Med Microbiol. 2005; 296(1):39-44. DOI: 10.1016/j.ijmm.2005.11.001. View

5.
WILKINSON H, Facklam R, Wortham E . Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun. 1973; 8(2):228-35. PMC: 422837. DOI: 10.1128/iai.8.2.228-235.1973. View